NBY
Novabay Pharmaceuticals
Description:
NovaBay Pharmaceuticals Inc. (NBY) is a California-based biotech company specializing in innovative solutions for ocular health, with a focus on advanced medical devices and therapeutics designed to treat eye infections and inflammation. Leveraging its proprietary technologies, NovaBay targets significant unmet clinical needs in the growing eye care market. As the company continues to develop and commercialize its product pipeline, it stands poised to improve patient outcomes, making it an attractive investment opportunity for institutional investors seeking to engage in the healthcare and medical device sectors.
Address:
2000 POWELL STREET, EMERYVILLE, CA, UNITED STATES, 94608
Fiscal year end:
December
Market capitalization:
$2.41 Billion
Dividend per share:
$0.00
How much was you spent on shares:
$1,000
How much will you earn in
10 years:
-100%
How much will you get:
$4
Prices dates:
31-12-2015: $1,522.77 and 31-12-2025: $5.64